Stage IA vs. IB endometrial stromal sarcoma: Does the new staging system predict survival?
Authors:
- 1 July 2010
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 118 (1) , 8-13
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patientsHistopathology, 2009
- Lymphadenectomy and Ovarian Preservation in Low-Grade Endometrial Stromal SarcomaObstetrics & Gynecology, 2008
- Utility of the SEER-Medicare Data to Identify Chemotherapy UseMedical Care, 2002
- Prognostic Parameters in Endometrial Stromal Sarcoma: A Clinicopathologic Study in 31 PatientsGynecologic Oncology, 2001
- The Outcome of Stage I–II Clinically and Surgically Staged Papillary Serous and Clear Cell Endometrial Cancers When Compared with Endometrioid CarcinomaGynecologic Oncology, 2000
- Smooth Muscle, Endometrial Stromal, and Mixed Müllerian Tumors of the UterusLaboratory Investigation, 2000
- The Prognostic Significance of Surgery, Tumor Size, Malignancy Grade, Menopausal Status, and DNA Ploidy in Endometrial Stromal SarcomaGynecologic Oncology, 1996
- Primary Uterine Endometrial Stromal NeoplasmsAmerican Journal of Surgical Pathology, 1990
- Endometrial stromal sarcomasGynecologic Oncology, 1990
- Endometrial stromal sarcoma: Review of mayo clinic experience, 1945–1980Gynecologic Oncology, 1989